Background: We are aware of no study that has indicated the effects of daily consumption of multispecies probiotic supplements on metabolic profiles, high-sensitivity C-reactive protein (hs-CRP), and oxidative stress in diabetic patients. Objective: This study was designed to determine the effects of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in diabetic patients. Methods: This randomized double-blind placebo-controlled clinical trial was performed on 54 diabetic patients aged 35-70 years. Subjects were randomly assigned to take either a multispecies probiotic supplement (n = 27) or placebo (n = 27) for 8 weeks. The multispecies probiotic supplement consisted of 7 viable and freeze-dried strains: Lactobacillus acidophilus (2 × 109 CFU), L. casei (7 × 109 CFU), L. rhamnosus (1.5 × 109 CFU), L. bulgaricus (2 × 108 CFU), Bifidobacterium breve (2 × 1010 CFU), B. longum (7 × 109 CFU), Streptococcus thermophilus (1.5 × 109 CFU), and 100 mg fructo-oligosaccharide. Fasting blood samples were taken at baseline and after intervention to measure metabolic profiles, hs-CRP, and biomarkers of oxidative stress including plasma total antioxidant capacity and total glutathione (GSH). Results: Between-group comparisons of fasting plasma glucose (FPG) revealed that consumption of probiotic supplements prevented a rise in FPG (+28.8 ± 8.5 for placebo vs. +1.6 ± 6 mg/dl for probiotic group, p = 0.01). Although a significant within-group increase in serum insulin and low-density lipoprotein cholesterol levels was found in both the probiotic group and the placebo group, the changes were similar between the two groups. We observed a significant increase in HOMA-IR (homeostasis model of assessment-insulin resistance) in both the probiotic group (p = 0.02) and the placebo group (p = 0.001); however, the increase in the placebo group was significantly higher than that in the probiotic group (+2.38 vs. +0.78, p = 0.03). Mean changes in serum hs-CRP were significantly different between the two groups (-777.57 for the probiotic group vs. +878.72 ng/ml for the placebo group, p = 0.02). Probiotic supplementation led to a significant increase in plasma GSH levels compared to placebo (240.63 vs. -33.46 µmol/l, p = 0.03). Conclusion: In conclusion, multispecies probiotic supplementation, compared with placebo, for 8 weeks in diabetic patients prevented a rise in FPG and resulted in a decrease in serum hs-CRP and an increase in plasma total GSH.

1.
Yan L, Hui G: Subcutaneous implanted system for the treatment of type 2 diabetes. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2011;33:473-477.
[PubMed]
2.
Neumann A, Schwarz P, Lindholm L: Estimating the cost-effectiveness of lifestyle intervention programmes to prevent diabetes based on an example from Germany: Markov modelling. Cost Eff Resour Alloc 2011;9:17.
[PubMed]
3.
Haghdoost AA, Rezazadeh-Kermani M, Sadghirad B, Baradaran HR: Prevalence of type 2 diabetes in the Islamic Republic of Iran: systematic review and meta-analysis. East Mediterr Health J 2009;15:591-599.
[PubMed]
4.
Ferreira L, Teixeira-de-Lemos E, Pinto F, Parada B, Mega C, Vala H, et al: Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat). Mediators Inflamm 2010;2010:592760.
[PubMed]
5.
Yadav H, Jain S, Sinha PR: Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 2007;23:62-68.
[PubMed]
6.
Shim U, Lee H, Oh JY, Sung YA: Sleep disorder and cardiovascular risk factors among patients with type 2 diabetes mellitus. Korean J Intern Med 2011;26:277-284.
[PubMed]
7.
Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, et al: The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess 2009;13:1-190, 215-357, iii-iv.
[PubMed]
8.
Zanuso S, Jimenez A, Pugliese G, Corigliano G, Balducci S: Exercise for the management of type 2 diabetes: a review of the evidence. Acta Diabetol 2010;47:15-22.
[PubMed]
9.
Huynh K, Kiriazis H, Du XJ, Love JE, Jandeleit-Dahm KA, Forbes JM, et al: Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes. Diabetologia 2012;55:1544-1553.
[PubMed]
10.
Abdulkadir AA, Thanoon IA: Comparative effects of glibenclamide and metformin on C-reactive protein and oxidant/antioxidant status in patients with type II diabetes mellitus. Sultan Qaboos Univ Med J 2012;12:55-61.
[PubMed]
11.
Undas A, Ariens RA: Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler Thromb Vasc Biol 2011;31:e88-e99.
[PubMed]
12.
Lye HS, Kuan CY, Ewe JA, Fung WY, Liong MT: The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens. Int J Mol Sci 2009;10:3755-3775.
[PubMed]
13.
Mallappa RH, Rokana N, Duary RK, Panwar H, Batish VK, Grover S: Management of metabolic syndrome through probiotic and prebiotic interventions. Indian J Endocrinol Metab 2012;16:20-27.
[PubMed]
14.
Kullisaar T, Songisepp E, Mikelsaar M, Zilmer K, Vihalemm T, Zilmer M: Antioxidative probiotic fermented goats' milk decreases oxidative stress-mediated atherogenicity in human subjects. Br J Nutr 2003;90:449-456.
[PubMed]
15.
Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V: Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 2012;28:539-543.
[PubMed]
16.
Lambert JM, Bongers RS, de Vos WM, Kleerebezem M: Functional analysis of four bile salt hydrolase and penicillin acylase family members in Lactobacillus plantarum WCFS1. Appl Environ Microbiol 2008;74:4719-4726.
[PubMed]
17.
Peran L, Camuesco D, Comalada M, Nieto A, Concha A, Adrio JL, et al: Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis. Int J Colorectal Dis 2006;21:737-746.
[PubMed]
18.
Kullisaar T, Zilmer M, Mikelsaar M, Vihalemm T, Annuk H, Kairane C, et al: Two antioxidative Lactobacilli strains as promising probiotics. Int J Food Microbiol 2002;72:215-224.
[PubMed]
19.
Hegazy SK, El-Bedewy MM: Effect of probiotics on pro-inflammatory cytokines and NF-kappaB activation in ulcerative colitis. World J Gastroenterol 2010;16:4145-4151.
[PubMed]
20.
Tabuchi M, Ozaki M, Tamura A, Yamada N, Ishida T, Hosoda M, et al: Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem 2003;67:1421-1424.
[PubMed]
21.
Naruszewicz M, Johansson ML, Zapolska-Downar D, Bukowska H: Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am J Clin Nutr 2002;76:1249-1255.
[PubMed]
22.
Zhang JW, Du P, Chen DW, Cui L, Ying CM: Effect of viable Bifidobacterium supplement on the immune status and inflammatory response in patients undergoing resection for colorectal cancer (in Chinese). Zhonghua Wei Chang Wai Ke Za Zhi 2010;13:40-43.
[PubMed]
23.
American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2012;35:S64-S71.
[PubMed]
24.
Erel O: A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004;37:277-285.
[PubMed]
25.
Surapaneni KM, Venkataramana G: Status of lipid peroxidation, glutathione, ascorbic acid, vitamin E and antioxidant enzymes in patients with osteoarthritis. Indian J Med Sci 2007;61:9-14.
[PubMed]
26.
Giacco F, Brownlee M: Oxidative stress and diabetic complications. Circ Res 2010;107:1058-1070.
[PubMed]
27.
White JR Jr: Economic considerations in treating patients with type 2 diabetes mellitus. Am J Health Syst Pharm 2002;59:S14-S17.
[PubMed]
28.
St-Onge MP, Farnworth ER, Savard T, Chabot D, Mafu A, Jones PJ: Kefir consumption does not alter plasma lipid levels or cholesterol fractional synthesis rates relative to milk in hyperlipidemic men: a randomized controlled trial (ISRCTN10820810). BMC Complement Altern Med 2002;2:1.
[PubMed]
29.
Ooi LG, Liong MT: Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int J Mol Sci 2010;11:2499-2522.
[PubMed]
30.
Cavallini DC, Bedani R, Bomdespacho LQ, Vendramini RC, Rossi EA: Effects of probiotic bacteria, isoflavones and simvastatin on lipid profile and atherosclerosis in cholesterol-fed rabbits: a randomized double-blind study. Lipids Health Dis 2009;8:1.
[PubMed]
31.
Naito E, Yoshida Y, Makino K, Kounoshi Y, Kunihiro S, Takahashi R, et al: Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice. J Appl Microbiol 2011;110:650-657.
[PubMed]
32.
Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, et al: Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007;50:2374-2383.
[PubMed]
33.
Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, et al: Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003;37:343-350.
[PubMed]
34.
Musso G, Gambino R, Cassader M: Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care 2010;33:2277-2284.
[PubMed]
35.
Membrez M, Blancher F, Jaquet M, Bibiloni R, Cani PD, Burcelin RG, et al: Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J 2008;22:2416-2426.
[PubMed]
36.
Konstantinov SR, Smidt H, de Vos WM, Bruijns SC, Singh SK, Valence F, et al: S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci USA 2008;105:19474-19479.
[PubMed]
37.
Ouwehand AC, Tiihonen K, Saarinen M, Putaala H, Rautonen N: Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters. Br J Nutr 2009;101:367-375.
[PubMed]
38.
Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V, et al: Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J Dairy Sci 2011;94:3288-3294.
[PubMed]
39.
Moroti C, Souza Magri LF, de Rezende Costa M, Cavallini DC, Sivieri K: Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus. Lipids Health Dis 2012;11:29.
[PubMed]
40.
Lewis S, Burmeister S, Cohen S, Brazier J, Awasthi A: Failure of dietary oligofructose to prevent antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2005;21:469-477.
[PubMed]
41.
Greany KA, Bonorden MJ, Hamilton-Reeves JM, McMullen MH, Wangen KE, Phipps WR, et al: Probiotic capsules do not lower plasma lipids in young women and men. Eur J Clin Nutr 2008;62:232-237.
[PubMed]
42.
Ribas V, Nguyen MT, Henstridge DC, Nguyen AK, Beaven SW, Watt MJ, et al: Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice. Am J Physiol Endocrinol Metab 2010;298:E304-E319.
[PubMed]
43.
Kiessling G, Schneider J, Jahreis G: Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. Eur J Clin Nutr 2002;56:843-849.
[PubMed]
44.
Smedman AE, Gustafsson IB, Berglund LG, Vessby BO: Pentadecanoic acid in serum as a marker for intake of milk fat: relations between intake of milk fat and metabolic risk factors. Am J Clin Nutr 1999;69:22-29.
[PubMed]
45.
Anderson AD, McNaught CE, Jain PK, MacFie J: Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 2004;53:241-245.
[PubMed]
46.
Asemi Z, Jazayeri S, Najafi M, Samimi M, Mofid V, Shidfar F, et al: Effects of daily consumption of probiotic yoghurt on inflammatory factors in pregnant women: a randomized controlled trial. Pak J Biol Sci 2011;14:476-482.
[PubMed]
47.
Hatakka K, Martio J, Korpela M, Herranen M, Poussa T, Laasanen T, et al: Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis - a pilot study. Scand J Rheumatol 2003;32:211-215.
[PubMed]
48.
Sugawara G, Nagino M, Nishio H, Ebata T, Takagi K, Asahara T, et al: Perioperative symbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg 2006;244:706-714.
[PubMed]
49.
Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh SV, O'Neil DA, et al: Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 2005;54:242-249.
[PubMed]
50.
Ranganathan N, Friedman EA, Tam P, Rao V, Ranganathan P, Dheer R: Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada. Curr Med Res Opin 2009;25:1919-1930.
[PubMed]
51.
Sadrzadeh-Yeganeh H, Elmadfa I, Djazayery A, Jalali M, Heshmat R, Chamary M: The effects of probiotic and conventional yoghurt on lipid profile in women. Br J Nutr 2010;103:1778-1783.
[PubMed]
52.
Kullisaar T, Songisepp E, Aunapuu M, Kilk K, Arend A, Mikelsaar M, et al: Complete glutathione system in probiotic Lactobacillus fermentum ME-3. Prikl Biokhim Mikrobiol 2010;46:527-531.
[PubMed]
53.
Lutgendorff F, Trulsson LM, van Minnen LP, Rijkers GT, Timmerman HM, Franzen LE, et al: Probiotics enhance pancreatic glutathione biosynthesis and reduce oxidative stress in experimental acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 2008;295:G1111-G1121.
[PubMed]
54.
Asemi Z, Jazayeri S, Najafi M, Samimi M, Mofid V, Shidfar F, et al: Effect of daily consumption of probiotic yogurt on oxidative stress in pregnant women: a randomized controlled clinical trial. Ann Nutr Metab 2012;60:62-68.
[PubMed]
55.
Hashem MA, Mohamed MH: Haemato-biochemical and pathological studies on aflatoxicosis and treatment of broiler chicks in Egypt. Vet Ital 2009;45:323-337.
[PubMed]
You do not currently have access to this content.